Literature DB >> 21693613

Early perfusion of a free RPE-choroid graft in patients with exudative macular degeneration can be imaged with spectral domain-OCT.

Elsbeth J T van Zeeburg1, Matteo G Cereda, Josine van der Schoot, Grazia Pertile, Jan C van Meurs.   

Abstract

PURPOSE: To study early flow and revascularization in a free, autologous, retinal pigment epithelium (RPE)-choroid graft.
METHODS: This prospective cohort study used spectral domain-optical coherence tomography (SD-OCT) after RPE-choroid graft surgery in 12 patients. This SD-OCT was combined with fluorescein angiography (FA) and indocyanine green angiography (ICGA) in 5 patients.
RESULTS: SD-OCT revealed that vessel diameter, number of vessels, and graft thickness increased in 10 of 12 patients, starting between 3 and 10 days after surgery. A subsequent decrease in thickness was found in all 10 patients, beginning as early as 8 days after surgery. Initially, the graft vessels were optically clearer than the underlying choroidal recipient vessels. Between 8 and 30 days after surgery, the optically clear vessels became gray, similar to the recipient choroid. FA and ICGA revealed perfusion in 4 of 5 patients between postoperative days 6 and 15. Between postoperative days 12 and 60, the entire choroidal structure of the graft was visible on ICGA. CONCLUSIONS; These data suggest that enlargement of vessel diameter, increase in the number of choroidal vessels, and graft thickening visualized by SD-OCT correspond with the ingrowth of afferent vessels, as demonstrated by ICGA. The subsequent establishment of efferent vessels results in flow, imaged as a change in color of the graft's vessels from optically clear to gray, graft thinning on SD-OCT, and complete revascularization on ICGA. SD-OCT, a noninvasive examination, can be used to demonstrate early graft perfusion in patients (trialregister.nl/trialreg/admin/rctview.asp number, NTR1768).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21693613     DOI: 10.1167/iovs.11-7245

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  OCT angiography documented reperfusion of translocated autologous full thickness RPE-choroid graft for complicated neovascular age-related macular degeneration.

Authors:  M Veckeneer; C Augustinus; E Feron; P-P Schauwvlieghe; J Ruys; I Cosemans; J Van Meurs
Journal:  Eye (Lond)       Date:  2017-07-21       Impact factor: 3.775

2.  Developing cellular therapies for retinal degenerative diseases.

Authors:  Kapil Bharti; Mahendra Rao; Sara Chandros Hull; David Stroncek; Brian P Brooks; Ellen Feigal; Jan C van Meurs; Christene A Huang; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-26       Impact factor: 4.799

Review 3.  Looking into the future: Using induced pluripotent stem cells to build two and three dimensional ocular tissue for cell therapy and disease modeling.

Authors:  Min Jae Song; Kapil Bharti
Journal:  Brain Res       Date:  2015-12-17       Impact factor: 3.252

4.  Direct Blood Flow Measurements in a Free RPE-Choroid Graft with Phase-Resolved Doppler OCT.

Authors:  Elsbeth J T van Zeeburg; Boy Braaf; Matteo G Cereda; Jan C van Meurs; Johannes F de Boer
Journal:  Transl Vis Sci Technol       Date:  2015-01-13       Impact factor: 3.283

5.  Visual acuity of 20/32, 13.5 years after a retinal pigment epithelium and choroid graft transplantation.

Authors:  Elsbeth J T van Zeeburg; Kristel J M Maaijwee; Jan C van Meurs
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-01

6.  Destructive inflammatory reaction after an autologous retinal pigment epithelium and choroid transplantation: no detection of an auto-immune response.

Authors:  Saskia H M van Romunde; Daphne P C Vergouwen; Daniela Iacovello; Dave L Roelen; Robert M Verdijk; Josianne C E M Ten Berge; Grazia Pertile; Marco W J Schreurs; Jan C van Meurs
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-08-26

7.  Optical biopsy of epithelial cancers by optical coherence tomography (OCT).

Authors:  R Wessels; D M De Bruin; D J Faber; T G Van Leeuwen; M Van Beurden; T J M Ruers
Journal:  Lasers Med Sci       Date:  2013-03-16       Impact factor: 3.161

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.